These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8992638)

  • 21. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
    Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
    Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation.
    Kusnierczyk NM; Saunders EF; Dupuis LL
    Bone Marrow Transplant; 2002 Jul; 30(2):119-24. PubMed ID: 12132051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escalating dose of oral ondansetron in the prevention of radiation induced emesis.
    Maisano R; Pergolizzi S; Settineri N
    Anticancer Res; 1998; 18(3B):2011-3. PubMed ID: 9677458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.
    Krobbuaban B; Pitakpol S; Diregpoke S
    J Med Assoc Thai; 2008 May; 91(5):669-74. PubMed ID: 18672630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
    Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone.
    Bano F; Zafar S; Aftab S; Haider S
    J Coll Physicians Surg Pak; 2008 May; 18(5):265-9. PubMed ID: 18541078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Jpn J Clin Oncol; 2009 Feb; 39(2):111-5. PubMed ID: 19060294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
    Zeidman A; Ben Dayan D; Ben Zion T; Kaufman O; Cohen AM; Mittelman M
    Haematologia (Budap); 1998; 29(1):25-31. PubMed ID: 9704254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient total body irradiation prior to bone marrow transplantation in pediatric patients: a feasibility analysis.
    Applegate GL; Mittal BB; Kletzel M; Morgan E; Johnson P; Danner K; Marymont MH
    Bone Marrow Transplant; 1998 Apr; 21(7):651-2. PubMed ID: 9578303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single i.v. bolus dose of ondansetron in the prevention of postoperative nausea and emesis.
    Moens P; Levarlet M; Hendrickx P; De Guchteneere E
    Acta Anaesthesiol Belg; 1997; 48(4):245-50. PubMed ID: 9526603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    ; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
    J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy.
    White L; Daly SA; McKenna CJ; Zhestkova N; Leal C; Breatnach F; Smelhaus V; Hung IJ; Kowalczyk J; Ninane J; Mitchell T; Haigh C
    Pediatr Hematol Oncol; 2000 Sep; 17(6):445-55. PubMed ID: 10989464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
    Argiriadou H; Papaziogas B; Pavlidis T; Parlapani A; Georgiou M; Papagiannopoulou P; Papaziogas T
    Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of the combination of oral ondansetron with methylprednisolone as soon as the first cure in mild emetogenic chemotherapy. Groupe français d'étude de l'ondansétron].
    Coiffier B; Khayat D; Misset JL; Votan B
    Bull Cancer; 1997 Aug; 84(8):781-7. PubMed ID: 9339181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.